Catheter Precision, Inc. (VTAK) Stock Price
VTAKStock
$0.21−93.09%52W
Market Cap$758,349.857
P/E—
PEG Ratio—
Div yield—
Beta-1.08
VTAK Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-98.96%
Price vs S&P 500 (4W)-28.48%
VGM Score55.63
VTAK Earnings Surprise History
Q1 24-68.40est. -7.98
Q2 24-105.83est. -4.94
Q3 24-38.19est. —
VTAK Analyst Recommendations
Jun 2025
Jul 2025
Aug 2025
Oct 2025
4.29
4.29
4.29
4.29
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
VTAKCatheter Precision, Inc. | B | A | F | $0.21 |
| SYKStryker Corporation | C | B | C | $330.59 |
| MMM3M Company | C | D | B | $179.37 |
| BSXBoston Scientific Corp. | C | B | D | $49.86 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.78 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.64 |
| RMDResMed Inc. | C | B | C | $236.59 |
| DXCMDexCom, Inc. | D | B | B | $89.16 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $348.48 |
| SOLVSolventum Corporation | C | C | B | $91.61 |
| BAXBaxter International Inc. | B | D | B | $26.29 |
About Catheter Precision, Inc.
Cathay Precision Inc is a medical device company specializing in cardiac electrophysiology solutions. Its lead product, the VIVO System, is a non-invasive 3D cardiac mapping platform for identifying ventricular arrhythmia origins prior to EP procedures and holds CE Mark approval for European commercialization. The company is expanding its product portfolio with LockeT, a surgical suture retention device designed to improve wound healing outcomes.